Results 131 to 140 of about 2,458 (200)

Expression Modulation of Immune Inhibitory Molecules by Small Molecule Inhibitor Drugs in Leukemic Cells of Chronic Lymphocytic Leukemia. [PDF]

Iran J Pharm Res
Mousavi-Mirkalaei F, Taghiloo S, Alizadeh-Foroutan M, Zaboli E, Eslami-Jouybari M, Shekarriz R, Mirzakhani L, Ehsani Z, Khosravi S, Karimpour F, Asgarian-Omran H.   +10 more
europepmc   +1 more source

Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma. [PDF]

Clin Cancer Res
Hanna GJ, Oakley LB, Shi R, ONeill A, Shin KY, Scarfo N, Sehgal K, Dennis MJ, Quinn N, Jo VY, Wong K, Shvyrkova A, Kushnarev V, Shanthappa BU, Tkachuk A, Kryukov K, Sarachakov A, Svekolkin V, Lennerz J, Waters S, Haddad RI.   +20 more
europepmc   +1 more source

Conventional and alternative approaches for targeting PIK3CA and PTEN alterations in head and neck, breast, and other cancers. [PDF]

Adv Biol Regul
Gencel-Augusto J, Grandis JR, Johnson DE.   +2 more
europepmc   +1 more source

Signaling pathways in systemic lupus erythematosus and therapeutic implications. [PDF]

Front Immunol
Balogh L, Kovács VG, Nagy G, Németh T.
europepmc   +1 more source

Update on Oral Oncolytics: A Focus on Hematology Drugs [PDF]

, 2020
Tadros, Monica
core   +1 more source

BV and beyond: how to incorporate novel agents into PTCL management. [PDF]

Hematology Am Soc Hematol Educ Program
Nizamuddin IA, Mehta-Shah N.
europepmc   +1 more source

Unraveling the many faces of angioimmunoblastic T-cell lymphoma: clinical, pathological, and molecular heterogeneity. [PDF]

Ann Hematol
Chen JP, Ke P, Qiu X, Xian QY, Wu JS, Feng C, Li HJ, Wang Y, Zhou JH.   +8 more
europepmc   +1 more source

A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities [PDF]

Ghione, Paola, Inghirami, Giorgio, Martin, Peter, Medico, Enzo, Medico, Giovanni, Piva, Roberto, Ruella, Marco, Tabbo, Fabrizio   +7 more
core   +1 more source

Emerging and Investigational Systemic Therapies in Recurrent/Metastatic Head and Neck Cancer After Progression on Immunotherapy. [PDF]

Cancers (Basel)
Abraham FF, Julian R.
europepmc   +1 more source

Update on Oral Oncolytics [PDF]

, 2020
Osmon, Elizabeth
core   +1 more source